Valeant Pharma (VRX) Short Interest Surges 56% - Guggenheim
In analyzing the latest short interest data for the Specialty Pharmaceutical sector, Guggenheim's Louise Chen notes that Valeant Pharma (NYSE: VRX) short interest rose 56.1% - the largest increase in the sector.
Valeant Pharma short interest was at 18,021,306 shares as of 03/31/2016, versus 11,548,303 shares as of 03/15/2016. Days to cover is still low at 0.37.
Meanwhile, the company with the largest decrease in short interest was Abbott (NYSE: ABT) at -26.2%.